Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0640

0.0%

Nov 7 3:22 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mammon who wrote (12659)	1/24/2014 1:54:03 PM
From: boomertree2	Read Replies (2) of 13111

Your continued positive view of PVCT management through rose bengal colored glasses is puzzling. When you wake up each morning do you expect Dees to ride in on his unicorn with your coffee and bagel? The Dec PR said we would have clarity from the FDA minute notes. The Company's summary of the published notes is inconsistent with what was promised by the PR. What is factually incorrect about my post? If I had characterized todays PR as providing the promised clarity, then that would have been incorrect. The Phase II MM study was finished in 2010. It is now 2014, the 4 PVCT execs have been paying themselves $1.1 million a year in comp, and we still don't have the promised clear path to approval.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next